Arcutis Biotherapeutics, Inc. -
ARIA INTELLIGENCE BRIEF
Disclosure records for this Health Care sector security show two members of Congress — Gil Cisneros and Josh Gottheimer — filing a combined three trades between April 2023 and May 2026, with two purchases and one sale reflecting a net-buying balance across that period. The congressional interest in this name is thin by volume, and no bipartisan co-trading clusters are recorded in the disclosure data. Separately, one executive-branch official has disclosed one transaction in the same security, representing an independent public-record sequence with no purchase-to-purchase proximity computed.
Signal Congress surfaces public disclosure data. This is not investment advice and does not imply wrongdoing.
TOTAL TRADES
3
BUYS
2
SELLS
1
MEMBERS
2
unique traders
BIPARTISAN CLUSTERS
0
AVG ALPHA 60D
-23.87%
vs SPY benchmark
ARQT timeline4 trades · Congress + cabinet · convergence
Positioned by disclosure date. Click any marker for its source filing.
CongressCabinetContract cut8-K13D▲ buy ▼ sell ◆ n/a ■ event
EXECUTIVE HOLDINGS
Primary-source OGE 278-T disclosures
| OFFICIAL | AGENCY | DATE | TYPE | AMOUNT |
|---|---|---|---|---|
Schuler, Frank Sr. Advisor | Feb 27, 25 | SELL | $1K–$15K |
3 trades
Congressional trading data from STOCK Act filings. Not investment advice.